US commits US$1M to strengthen Tanzania’s Mpox response

TANZANIA—The United States government, through the U.S. Centers for Disease Control and Prevention (CDC), has announced nearly US$1 million in new funding to help Tanzania strengthen its response to mpox (formerly known as monkeypox).

This support is aimed at both mainland Tanzania and Zanzibar, focusing on improving the country’s ability to detect, monitor, and control the spread of the disease.

This financial assistance will enable Tanzania’s Ministries of Health to enhance surveillance systems, allowing for quicker identification of new mpox cases and emerging infection clusters.

 By strengthening these surveillance efforts, health authorities can respond more rapidly and effectively to outbreaks, reducing the risk of further spread.

In addition, the funding will help expand infection prevention and control measures within healthcare facilities across the country.

This includes providing essential laboratory materials, which are critical for accurate testing and diagnosis of mpox.

 The initiative will also boost the capacity at key points of entry-such as airports and border crossings-to prevent the importation or exportation of the virus.

Another important aspect of the support involves reinforcing Tanzania’s Emergency Operations Centers (EOCs).

These centers play a vital role in analyzing data, coordinating responses, and preparing situation reports that offer detailed demographic and regional information about mpox cases.

By improving data analysis and communication, the EOCs can better guide public health strategies and resource allocation.

Public communication and awareness are also central to this effort. The U.S. funding will support campaigns to inform communities about mpox symptoms, prevention, and the importance of seeking medical care early.

Typical symptoms of mpox include a painful rash, swollen lymph nodes, fever, headache, muscle aches, and fatigue.

While most people recover without complications, some can develop severe illness, making early detection and treatment essential.

Chargé d’Affaires a.i. Andrew Lentz emphasized the U.S. government’s commitment to working closely with Tanzania in the fight against infectious diseases.

 He noted that these investments reaffirm the longstanding partnership between the two countries, aimed at strengthening Tanzania’s resilience to disease outbreaks.

Lentz added that the United States is proud to contribute its technical expertise and resources to protect the health and safety of both Americans and Tanzanians.

This initiative is part of a broader global effort led by the United States and international partners to address the ongoing mpox outbreaks in Africa.

The U.S. has pledged significant resources, including financial support and vaccine donations, to help countries across the continent prepare for and respond to mpox.

These efforts are designed not only to safeguard the health of local populations but also to reduce the risk of global spread, making the world safer for everyone.

By supporting Tanzania’s mpox response, the United States is helping to build stronger public health systems and improve preparedness for future outbreaks.

This collaborative approach underscores the importance of international cooperation in tackling emerging health threats.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.